← Back to Search

Behavioral Intervention

Mindfulness Intervention for Autism Spectrum Disorder

N/A
Recruiting
Led By Nicole Matthews, Ph.D.
Research Sponsored by Southwest Autism Research & Resource Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Adolescents must be ages 13 to 18 years
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention (8 weeks); 2-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to develop interventions to help teenagers with Autism Spectrum Disorder (ASD) who also experience stress, anxiety, and depression.

Who is the study for?
This trial is for English-speaking adolescents aged 13-18 with a formal ASD diagnosis and their caregivers. Participants must commit to attending at least 7 of the 8 group meetings.
What is being tested?
The study tests 'MINDful TIME,' an intervention aimed at improving mental health symptoms like stress, anxiety, and depression in adolescents with Autism Spectrum Disorder (ASD).
What are the potential side effects?
Since this is a mindfulness-based intervention, there are no direct medical side effects; however, participants may experience emotional discomfort or fatigue during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 13 and 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention (8 weeks); 2-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention (8 weeks); 2-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean Change from Baseline in Child and Adolescent Mindfulness Measure (CAMM) Scores
Mean Change from Baseline in Children's Depression Inventory (CDI) Scores
Mean Change from Baseline in Multidimensional Anxiety Scale for Children (MASC) Scores
Secondary study objectives
Mean Change from Baseline in Adaptive Behavior Assessment System (ABAS-3) Scores
Mean Change from Baseline in Beck Youth Inventories (BYI) Scores
Mean Change from Baseline in Behavior Rating Inventory of Executive Function (BRIEF) Scores
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MINDful TIME groupExperimental Treatment1 Intervention
8-week mindfulness-based intervention for adolescents with ASD and their caregivers. Weekly meetings will be held in-person and will last approximately 2-hours. Adolescents and their caregivers will be asked to engage in home practice outside of group meetings
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MINDful TIME
2023
N/A
~50

Find a Location

Who is running the clinical trial?

Southwest Autism Research & Resource CenterLead Sponsor
8 Previous Clinical Trials
958 Total Patients Enrolled
8 Trials studying Autism Spectrum Disorder
958 Patients Enrolled for Autism Spectrum Disorder
Arizona State UniversityOTHER
298 Previous Clinical Trials
107,909 Total Patients Enrolled
9 Trials studying Autism Spectrum Disorder
735 Patients Enrolled for Autism Spectrum Disorder
Nicole Matthews, Ph.D.Principal InvestigatorSouthwest Autism Research & Resource Center
~19 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top